Meifeng Xu

4.7k total citations · 1 hit paper
67 papers, 3.9k citations indexed

About

Meifeng Xu is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Meifeng Xu has authored 67 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 24 papers in Surgery and 18 papers in Genetics. Recurrent topics in Meifeng Xu's work include Tissue Engineering and Regenerative Medicine (23 papers), Mesenchymal stem cell research (18 papers) and Electrospun Nanofibers in Biomedical Applications (11 papers). Meifeng Xu is often cited by papers focused on Tissue Engineering and Regenerative Medicine (23 papers), Mesenchymal stem cell research (18 papers) and Electrospun Nanofibers in Biomedical Applications (11 papers). Meifeng Xu collaborates with scholars based in United States, China and Singapore. Meifeng Xu's co-authors include Yigang Wang, Muhammad Ashraf, Muhammad Ashraf, Ryota Uemura, Nauman Ahmad, Ronald W. Millard, Zeeshan Pasha, Bin Yu, Min Gong and Ahmar Ayub and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Meifeng Xu

64 papers receiving 3.8k citations

Hit Papers

Bone Marrow Stem Cells Prevent Left Ventricular Remodelin... 2006 2026 2012 2019 2006 100 200 300 400 500

Peers

Meifeng Xu
Husnain Kh Haider United States
Huamei He United States
Arjun Deb United States
Sonja Schrepfer United States
Meifeng Xu
Citations per year, relative to Meifeng Xu Meifeng Xu (= 1×) peers Luis G. Melo

Countries citing papers authored by Meifeng Xu

Since Specialization
Citations

This map shows the geographic impact of Meifeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meifeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meifeng Xu more than expected).

Fields of papers citing papers by Meifeng Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meifeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meifeng Xu. The network helps show where Meifeng Xu may publish in the future.

Co-authorship network of co-authors of Meifeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Meifeng Xu. A scholar is included among the top collaborators of Meifeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meifeng Xu. Meifeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Xin, Hao Wu, Mengqi He, et al.. (2025). Preparation and performance of a superhydrophobic SERS substrate with a multilevel structure composed of micro-protrusions and nanoneedles. Surfaces and Interfaces. 60. 105998–105998.
2.
Zhu, Qi, Nathan Qi, Ling Shen, et al.. (2023). Sexual Dimorphism in Lipid Metabolism and Gut Microbiota in Mice Fed a High-Fat Diet. Nutrients. 15(9). 2175–2175. 13 indexed citations
3.
Jiang, Lin, Jialiang Liang, Wei Huang, et al.. (2021). CRISPR activation of endogenous genes reprograms fibroblasts into cardiovascular progenitor cells for myocardial infarction therapy. Molecular Therapy. 30(1). 54–74. 32 indexed citations
4.
Cai, Wenfeng, Kai Kang, Wei Huang, et al.. (2015). CXCR4 attenuates cardiomyocytes mitochondrial dysfunction to resist ischaemia‐reperfusion injury. Journal of Cellular and Molecular Medicine. 19(8). 1825–1835. 16 indexed citations
5.
Wang, Yuhua, Wei Huang, Zhili Wen, et al.. (2014). Suicide Gene-Mediated Sequencing Ablation Revealed the Potential Therapeutic Mechanism of Induced Pluripotent Stem Cell-Derived Cardiovascular Cell Patch Post-Myocardial Infarction. Antioxidants and Redox Signaling. 21(16). 2177–2191. 7 indexed citations
6.
Yang, Huaxiao, Qin Wan, Thomas K. Borg, et al.. (2014). Enzyme-etching technique to fabricate micropatterns of aligned collagen fibrils. Biotechnology Letters. 36(6). 1245–1252. 2 indexed citations
7.
Huang, Wei, Yuliang Feng, Jialiang Liang, et al.. (2013). Abstract 10616: Mir-128 Targets E2f3 to Regulate Cardiomyocyte Cell Cycle Re-entry. Circulation. 128. 1 indexed citations
8.
Yu, Bin, Min Gong, Yigang Wang, et al.. (2013). Cardiomyocyte Protection by GATA-4 Gene Engineered Mesenchymal Stem Cells Is Partially Mediated by Translocation of miR-221 in Microvesicles. PLoS ONE. 8(8). e73304–e73304. 112 indexed citations
9.
Ma, Zhen, Huaxiao Yang, Meifeng Xu, et al.. (2013). Mesenchymal Stem Cell-Cardiomyocyte Interactions under Defined Contact Modes on Laser-Patterned Biochips. PLoS ONE. 8(2). e56554–e56554. 37 indexed citations
10.
11.
Deng, Zhiwei, et al.. (2012). Application of NMR Techniques in Pharmaceutical Assay. Journal of Instrumental Analysis. 31(9). 1081–1088. 1 indexed citations
12.
Shao, Yonghong, Qin Wan, Raymond B. Runyan, et al.. (2012). Myosin filament assembly onto myofibrils in live neonatal cardiomyocytes observed by TPEF-SHG microscopy. Cardiovascular Research. 97(2). 262–270. 27 indexed citations
13.
Liang, Jialiang, Wei Huang, Xi‐Yong Yu, et al.. (2012). Suicide Gene Reveals the Myocardial Neovascularization Role of Mesenchymal Stem Cells Overexpressing CXCR4 (MSCCXCR4). PLoS ONE. 7(9). e46158–e46158. 26 indexed citations
14.
Jones, W. Keith, Hongxia Li, Zhisong He, et al.. (2011). Paracrine Effect of Wnt11-Overexpressing Mesenchymal Stem Cells on Ischemic Injury. Stem Cells and Development. 21(4). 598–608. 43 indexed citations
15.
He, Zhisong, Hongxia Li, Zeeshan Pasha, et al.. (2011). Transduction of Wnt11 Promotes Mesenchymal Stem Cell Transdifferentiation into Cardiac Phenotypes. Stem Cells and Development. 20(10). 1771–1778. 33 indexed citations
16.
Ma, Zhen, Qiuying Liu, Huaxiao Yang, et al.. (2011). Laser-patterned stem-cell bridges in a cardiac muscle model for on-chip electrical conductivity analyses. Lab on a Chip. 12(3). 566–573. 30 indexed citations
17.
Huang, Wei, Jialiang Liang, Meifeng Xu, et al.. (2011). Abstract 9990: Regulation of miR132 in Cardiac Fibroblasts After Ischemia Enhances Angiogenesis and Reduction of Apoptosis by Targeting Sonic Hedgehog. Circulation. 124(suppl_21). 1 indexed citations
18.
Li, Hongxia, Zeeshan Pasha, Bin Yu, et al.. (2011). GATA-4 promotes myocardial transdifferentiation of mesenchymal stromal cells via up-regulating IGFBP-4. Cytotherapy. 13(9). 1057–1065. 32 indexed citations
19.
Huang, Wei, Dongsheng Zhang, Ronald W. Millard, et al.. (2009). Gene manipulated peritoneal cell patch repairs infarcted myocardium. Journal of Molecular and Cellular Cardiology. 48(4). 702–712. 32 indexed citations
20.
Xu, Meifeng & Muhammad Ashraf. (2002). Melatonin Protection Against Lethal Myocyte Injury Induced by Doxorubicin as Reflected by Effects on Mitochondrial Membrane Potential. Journal of Molecular and Cellular Cardiology. 34(1). 75–79. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026